Xoma | XOMA - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
AbbVie USD 5.57B 2.9B 2026-03
Agenus USD -10.61M 263.52M 2025-12
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Ardelyx USD -400K 467K 2025-12
aTyr Pharma USD -25.75M 6.22M 2025-09
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Celldex Therapeutics USD -81.32M 14.27M 2025-12
Curis USD 19.36M 33.34M 2025-12
Eli Lilly USD 8.27B 1.03B 2025-12
Incyte USD 343.6M 46.34M 2026-03
MacroGenics USD -14.93M 31.75M 2025-12
Novartis USD 3.84B 802M 2026-03
Novartis USD 5.17B 637M 2025-09
Pfizer USD 5.18B 6.82B 2026-03
Prothena USD -21.58M 15.33M 2025-12
Regeneron Pharmaceuticals USD 1.04B 719.6M 2025-12
Xoma USD 15.98M 24.58M 2024-06